Viridian Therapeutics
VRDN
VRDN
26 hedge funds and large institutions have $109M invested in Viridian Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
70.56% less ownership
Funds ownership: 141.77% → 71.22% (-71%)
Holders
26
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$14.5M | |
| 2 | +$9.73M | |
| 3 | +$3.39M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$3.28M |
| 5 |
Millennium Management
New York
|
+$1.36M |
Top Sellers
| 1 | -$9.19M | |
| 2 | -$2.13M | |
| 3 | -$2.07M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.13M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$557K |